Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile-Reference-Cited by-同舟云学术

Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile

Published:2010-11-16 Issue:6 Volume:73 Page:769-776
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Rasmussen Michael Højby,Jensen Lene,Anderson Thomas W.,Klitgaard Thomas,Madsen Jesper

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2010.03863.x/fullpdf

Reference27 articles.

1. Growth hormone deficiency in children;Richmond;Pituitary,2008

2. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline;Molitch;Journal of Clinical Endocrinology & Metabolism,2006

3. GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia;Ho;European Journal of Endocrinology,2007

4. Compliance with growth hormone treatment - are they getting it?;Smith;Archives of Disease in Childhood,1993

5. Patient outcomes in the GH-Monitor: the effect of delivery device on compliance and growth;Desrosiers;Pediatric Endocrinology Reviews,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone receptor agonists and antagonists: From protein expression and purification to long‐acting formulations;Protein Science;2023-08-22

2. Metabolomic Differential Compounds Reflecting the Clinical Efficacy of Polyethylene Glycol Recombinant Human Growth Hormone in the Treatment of Childhood Growth Hormone Deficiency;Frontiers in Pharmacology;2022-04-27

3. Adult growth hormone deficiency: clinical advances and approaches to improve adherence;Expert Review of Endocrinology & Metabolism;2019-11-02

4. The current state of long-acting growth hormone preparations for growth hormone therapy;Current Opinion in Endocrinology & Diabetes and Obesity;2018-08

5. A long‐acting pegylated recombinant human growth hormone (Jintrolong ® ) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics;Journal of Clinical Pharmacy and Therapeutics;2018-06-29